Εμφανίζονται 1 - 20 Αποτελέσματα από 77 για την αναζήτηση '"СИНДРОМ СЛАБОСТИ СИНУСОВОГО УЗЛА"', χρόνος αναζήτησης: 0,75δλ Περιορισμός αποτελεσμάτων
  1. 1
  2. 2
    Academic Journal

    Περιγραφή αρχείου: application/pdf

    Relation: Капусник Ю. О. Особливості діагностики та фармакотерапії порушень ритму і провідності у хворих із синдромом слабкості синусового вузла / Ю. О. Капусник // Вісник проблем біології і медицини. – 2019. – Вип. 4, том 2 (154). – С. 18–28.; https://repository.pdmu.edu.ua/handle/123456789/12502

  3. 3
  4. 4
    Academic Journal

    Πηγή: Complex Issues of Cardiovascular Diseases; Том 7, № 3 (2018); 24-32 ; Комплексные проблемы сердечно-сосудистых заболеваний; Том 7, № 3 (2018); 24-32 ; 2587-9537 ; 2306-1278 ; 10.17802/2306-1278-2018-7-3

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.nii-kpssz.com/jour/article/view/449/343; Lip G.Y., Nieuwlaat R., Pisters R., Lane D.A., Crijns H.J. Refining clinical risk stratification for predicting stroke and tromboembolism in atrial fibrillation using a novel risk factorbased approach the euro heart survey on atrial fibrillation. CHEST. 2010; 137: 263–272. doi:10.1378/chest.09-1584; Татарский Б.А., Баталов Р.Е., Попов С.В. Фибрилляция предсердий: патофизиологические подходы к выбору антиаритмической терапии. Томск: STT, 2013; 484 с.; Канорский С.Г., Канорская Ю.С. Фибрилляция предсердий у больных с сахарным диабетом 2-го типа: особенности развития и противорецидивной терапии. Кардиология. 2010; 50 (7): 38–42.; Rutter M. K., Parise H., Benjamin E.J., Levy D., Larson M.G., Meigs J.B. et al. Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study. Circulation. 2003; 107: 448–454.; Sharma A.D., Rizo-Patron C., Hallstrom A.P., O'Neill G.P., Rothbart S., Martins J.B. et al. DAVID Investigators Percent right ventricular pacing predicts outcomes in the DAVID Trial. Heart Rhythm. 2005; 2:830–834.; Carsten W. The role of pacing mode in the development of atrial fibrillation. Europace. 2006; 8(2): 89–95. DOI:10.1093/europace/euj038.; Augello G., Vicedomini G., Saviano M., Crisa S., Mazzone P., Ornago O. et al. Pulmonary vein isolation after circumferential pulmonary vein ablation: comparison between Lasso and three-dimensional electroanatomical assessment of complete electrical disconnection. Heart Rhythm. 2009; 6(12):1706–13. doi:10.1016/j.hrthm.2009.09.008; Yu H.T., Shim J., Park J., Kim I.S., Kim T.H., Uhm J.S. et al. Pulmonary Vein Isolation Alone Versus Additional Linear Ablation in Patients With Persistent Atrial Fibrillation Converted to Paroxysmal Type With Antiarrhythmic Drug Therapy: A Multicenter, Prospective, Randomized Study. Circ Arrhythm Electrophysiol. 2017; 10(6). pii: e004915. doi:10.1161/CIRCEP.116.004915.; Kettering K, Yim DH, Gramley F. Catheter ablation of persistent atrial fibrillation : Circumferential pulmonary vein ablation: beneficial effect of an additional linear lesion at the roof of the left atrium on the long-term outcome. Herzschrittmacherther Elektrophysiol. 2017; 5(3):75–82. doi:10.1007/s00399-017-0519-x; Haissaguerre M., Marcus F.I., Fischer B., Clémenty J. Radiofrequency catheter ablation in unusual mechanisms of atrial fibrillation: report of three cases. J Cardiovasc Electrophysiol. Sep 1994; 5(9):743–751.; Osaka Y., Takigawa M., Takahashi A., Takahashi A., Kuwahara T., Okubo K., Takahashi Y. et al. The proportion of asymptomatic recurrence after catheter ablation of atrial fibrillation in patients with a pacemaker for sick sinus syndrome. Indian Pacing Electrophysiol J. 2017: 125–131. doi:10.1016/j.ipej.2017.07.009; Елесин Д.А., Романов А.Б., Туров А.Н., Шабанов В.В., Стенин И.Г., Якубов А.А. и др. Радиочастотная аблация пароксизмальной и длительно персистирующей форм фибрилляции предсердий: 1-летний период наблюдения с помощью непрерывного подкожного мониторирования. Вестник аритмологии. 2011; 63: 5–11.; Kato T., Yamashita T., Sekiguchi A., Sagara K., Takamura M., Takata S. et al. What are arrhythmogenic substrates in diabetic rat atria. J Cardiovasc Electrophysiol. 2006; 17:890–894. DOI:10.1111/j.1540-8167.2006.00528.x

  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
    Academic Journal

    Πηγή: Rational Pharmacotherapy in Cardiology; Vol 7, No 2 (2011); 174-176 ; Рациональная Фармакотерапия в Кардиологии; Vol 7, No 2 (2011); 174-176 ; 2225-3653 ; 1819-6446 ; 10.20996/1819-6446-2011-7-2

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.rpcardio.com/jour/article/view/746/774; Hewett К., Norman L.W., Sedmera D. et al. Knockout of the neural and heart expressed gene HF-1b results in apical deficits of ventricular structure and activation. Cardiovascular research 2005; 67: 548-560; Nguyên-Trân V.T., Kubalak S.W., Minamisawa S. et al. A novel genetic pathway for sudden cardiac death via defects in the transition between ventricular and conduction system cell lineages. Cell 2000; 102(5): 671-682.; Amand T.R., Lu J.T., Chien K.R. Defects in cardiac conduction system lineages and malignant arrhythmias: developmental pathways and disease. Novartis Found Symp 2003;250:260-70.; Willecke K., Elberger J., Degen J. et al. Structural and functional diversity of connexin genes in the mouse and human genome. Biol Chem 2002; 383: 725–737; Hagendorff A., Schumacher B., Kirchhoff S. et al. Conduction disturbances and increased atrial vulnerability in Connexin 40-deficient mice analyzed by transesophageal stimulation. Circulation 1999; 99(11): 1508-15; Firouzi M., Ramanna H., Kok B. et al. Association of Human Connexin40 Gene Polymorphisms With Atrial Vulnerability as a Risk Factor for Idiopathic Atrial Fibrillation. Circulation Research 2004; 95: e29; Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning: A Laboratory Manual. N.Y. : Cold Spring Harbor Laboratory; 1982.; Smith C.L., Kalco S.R. Cantor C.R. Pulsed field gel electrophoresis and the technology oflarge DNA molecules. In: R.E. Davis, Ed. Genome analysis. A practical approach. 1st ed. Davis RE, ed. Oxford: IRL Press, 1988: 41-72.; Juang J.M., Chern Y.R., Tsai C.T. et al. The association of human connexin 40 genetic polymorphisms with atrial fibrillation. Int J Cardiol 2007;116(1):107-12.; Groenewegen W.A., Firouzi M., Bezzina C.R. et al. A Cardiac Sodium Chanall Mutation Cosegregates With a Rare Connexine 40 Genotype in Familial Atrial Standstill. Circ Res 2003; 92:14-22.; Gollob M.H., Jones D.L., Krahn A.D. et al. Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation. New Eng J Med 2006; 354: 2677-2688.; https://www.rpcardio.com/jour/article/view/746

  12. 12
    Academic Journal

    Πηγή: Rational Pharmacotherapy in Cardiology; Vol 3, No 5 (2007); 58-61 ; Рациональная Фармакотерапия в Кардиологии; Vol 3, No 5 (2007); 58-61 ; 2225-3653 ; 1819-6446 ; 10.20996/1819-6446-2007-3-5

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.rpcardio.com/jour/article/view/548/569; Lown B. Electrical conversion of cardiac arrhythmias. J Chron Dis 1965;18:899-904.; Сыркин А. Л., Недоступ А. В., Маевская И. В. Электроимпульсное лечение в клинике внутренних болезней. М.: Медицина; 1970.; Cohn A., Lewis T. Auricular fibrillation and complete heart block: a description of a case of Adams-Stokes syndrome including the post-mortem examination. Heart 1912-1913;4:15-32.; Levine S. A. Observation on sinoauricular heart block. Arch Intern Med 1916;17:153-75.; Thery C., Cosselin B., Lekieffre J., Warembourg H. Pathology of sinoatrial node. Correlation with electrocardiographic findings in 11 patients. Am Heart J 1977;93(6):735-40.; Bacos J. M., Eagain J. T., Orgain E. S. Congenital familial nodal rhythm. Circulation 1960;22:887-95.; Rokseth R., Hatle L. Prospective study on the occurrence and management of chronic sinoatrial disease with follow up. Brit Heart J 1974;36:582-7.; Mackintosh A.F., Chamberlain D.A. Sinus node disease affecting both parents and both children. Eur J Cardiol 1979;10(2):117-22.; Spellberg R. D. Familial sinus node disease. Chest 1971;60(3):246-51; Livesley B., Caralis P. F., Oram S. Familial sinoatrial disorder. Brit Heart J 1972;34:668-70.; Disertori M, Guarnerio M, Vergara G, et al. Familial endemic persistent atrial standstill in a small mountain community: review of eight cases. Eur Heart J 1983;4:354-61.; Caralis G., Varghese P. Familial sinoatrial dysfunction. Increased vagal tone a possible etiology. Br Heart J 1976;9:956-7.; Nordenberg A, Varghese PJ, Nugent EW. Spectrum of sinus node dysfunction in two siblings. Am Heart J. 1976;91(4):507-12.; Beer J., Meithae B., Ducam H. et al. Maladie du sinas a propos dune observation. Coeur 1976;7(2):233-45.; Benson D. W. Genetics of atrioventricular conduction disease in humans. Anat Rec A Discov Mol Cell Evol Biol 2004;280(2):934-9.; Shulze-Bahr E., Neu A., Friederich P., et al. Pacemaker channel dysfunction in a patient with sinus node disease. J Clin Invest 2003;111:1537- 45.; https://www.rpcardio.com/jour/article/view/548

  13. 13
    Academic Journal

    Πηγή: Rational Pharmacotherapy in Cardiology; Vol 6, No 5 (2010); 662-666 ; Рациональная Фармакотерапия в Кардиологии; Vol 6, No 5 (2010); 662-666 ; 2225-3653 ; 1819-6446 ; 10.20996/1819-6446-2010-6-5

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.rpcardio.com/jour/article/view/964/998; Benson D.W. Genetics of atrioventricular conduction disease in humans. Anat Rec A Discov Mol Cell Evol Biol 2004;280(2):934-939.; Schulze-Bahr E., Neu A., Friederich P. et al. Pacemaker channel dysfunction in a patient with sinus node disease. J Clin Invest 2003;111(10):1537-1545.; Milanesi R., Baruscotti M., Gnecchi-Ruscone T., DiFrancesco D. Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel. N Engl J Med 2006;354(2): 151-7.; Probst V., Kyndt F., Allouis M. et al. Genetic aspects of cardiac conduction defects. Arch Mal Coeur Vaiss 2003;96(11):1067-73; Link R.E., Desai K., Hein L. et al. Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypes b Science 1996;273(5276):803-805.; Siitonen N., Lindström J., Eriksson J. et al. Association between a deletion/insertion polymorphism in the alpha2B-adrenergic receptor gene and insulin secretion and Type 2 diabetes. The Finnish Diabetes Prevention Study. Diabetologia 2004;47(8):1416-1424.; Hein L., Altman J.D., Kobilka B.K. Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission. Nature 1999; 402(6758):181-184.; Ham J., Rees D.A. The adenosine a2b receptor: its role in inflammation. Endocr Metab Immune Disord Drug Targets 2008;8(4):244-254.; Grenz A., Osswald H., Eckle T. et al. The reno-vascular A2B adenosine receptor protects the kidney from ischemia. Plos Med 2008; 5(6):e137.; Snapir A., Heinonen P., Tuomainen T.P. et al. An insertion/deletion polymorphism in the alpha2B-adrenergic receptor gene is a novel genetic risk factor for acute coronary events. J Am Coll Cardiol 2001;37(6):1516-1522.; Vasudevan R., Ismail P., Stanslas J. et al. Association of Insertion/Deletion Polymorphism of Alpha-Adrenoceptor Gene in Essential Hypertension with or without Type 2 Diabetes Mellitus in Malaysian Subjects. Int J Biol Sci 2008;4(6):362-367.; Snapir A., Scheinin M., Groop L.C., Orho-Melander M. The insertion/deletion variation in the α2B-adrenoceptor does not seem to modify the risk for acute myocardial infarction, but may modify the risk for hypertension in sib-pairs from families with type 2 diabetes. Cardiovasc Diabetol 2003;24(2):15.; Heinonen P., Koulu M., Pesonen U. et al. Identification of a three-amino acid deletion in the alpha2B-adrenergic receptor that is associated with reduced basal metabolic rate in obese subjects. J Clin Endocrinol Metab 1999;84(7):2429-2433.; Von Wowern F., Bengtsson K., Lindblad U. et al. Functional variant in the (alpha)2B adrenoceptor gene, a positional candidate on chromosome 2, associates with hypertension. Hypertension 2004;43(3):592-597.; Baldwin C.T., Schwartz F., Baima J. et al. Identification of a polymorphic glutamic acid stretch in the alpha2B-adrenergic receptor and lack of linkage with essential hypertension. Am J Hypertens 1999:12(9):853-857.; Etzel J.P., Rana B.K., Wen G. et al. Genetic variation at the human alpha2B-adrenergic receptor locus: role in blood pressure variation and yohimbine response. Hypertension 2005;45(6):1207-1213.; Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning: A Laboratory Manual. New York: Cold Spring Harbor Laboratory Press; 1989.; Smith C.L., Kalco S.R. Cantor CR. Pulsed field gel electrophoresis and the technology oflarge DNA molecules. In: Davis R.E., Ed. Genome analysis. Washington: IRL Press; 1988. P. 41- 72.; https://www.rpcardio.com/jour/article/view/964

  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20